All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel
.
Security |
Imputed Share Price |
Prev Shares |
Current Shares |
Change (Percent) |
Prev Value (USD x1000) |
Current Value (USD x1000) |
Change (Percent) |
ACET / Adicet Bio, Inc.
|
|
|
|
|
|
|
|
ANAB / AnaptysBio, Inc.
|
|
|
|
|
|
|
|
ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
RXDX / Prometheus Biosciences Inc
|
|
|
|
|
|
|
|
RAIN / Rain Enhancement Technologies Holdco, Inc.
|
|
|
|
|
|
|
|
EWTX / Edgewise Therapeutics, Inc.
|
|
|
|
|
|
|
|
BEAM / Beam Therapeutics Inc.
|
|
|
|
|
|
|
|
CLDX / Celldex Therapeutics, Inc.
|
|
|
|
|
|
|
|
IGMS / IGM Biosciences, Inc.
|
|
|
|
|
|
|
|
SRNE / Sorrento Therapeutics, Inc.
|
|
|
|
|
|
|
|
MYOV / Myovant Sciences Ltd
|
|
|
|
|
|
|
|
ACRS / Aclaris Therapeutics, Inc.
|
|
|
|
|
|
|
|
CNTB / Connect Biopharma Holdings Limited - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
GLUE / Monte Rosa Therapeutics, Inc.
|
|
|
|
|
|
|
|
STOK / Stoke Therapeutics, Inc.
|
|
|
|
|
|
|
|
CHAQ / Chardan Healthcare Acquisition 2 Corp
|
|
|
|
|
|
|
|
BBIO / BridgeBio Pharma, Inc.
|
|
|
|
|
|
|
|
KROS / Keros Therapeutics, Inc.
|
|
|
|
|
|
|
|
OMER / Omeros Corporation
|
|
|
|
|
|
|
|
INSP / Inspire Medical Systems, Inc.
|
|
|
|
|
|
|
|
VERU / Veru Inc.
|
|
|
|
|
|
|
|
GOSS / Gossamer Bio, Inc.
|
|
|
|
|
|
|
|
ALXO / ALX Oncology Holdings Inc.
|
|
|
|
|
|
|
|
AKRO / Akero Therapeutics, Inc.
|
|
|
|
|
|
|
|
XFOR / X4 Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
OTLK / Outlook Therapeutics, Inc.
|
|
|
|
|
|
|
|
BCEL / Atreca, Inc.
|
|
|
|
|
|
|
|
CYTK / Cytokinetics, Incorporated
|
|
|
|
|
|
|
|
OLMA / Olema Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
BCAB / BioAtla, Inc.
|
|
|
|
|
|
|
|
VTYX / Ventyx Biosciences, Inc.
|
|
|
|
|
|
|
|
QURE / uniQure N.V.
|
|
|
|
|
|
|
|
GHRS / GH Research PLC
|
|
|
|
|
|
|
|
MRUS / Merus N.V.
|
|
|
|
|
|
|
|
RCKT / Rocket Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
SONX / Sonendo, Inc.
|
|
|
|
|
|
|
|
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
QTNT / Quotient Ltd
|
|
|
|
|
|
|
|
MGTA / Magenta Therapeutics Inc
|
|
|
|
|
|
|
|
AGEN / Agenus Inc.
|
|
|
|
|
|
|
|
RETA / Reata Pharmaceuticals Inc - Class A
|
|
|
|
|
|
|
|
DCPH / Deciphera Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
DTIL / Precision BioSciences, Inc.
|
|
|
|
|
|
|
|
DMTK / DermTech, Inc.
|
|
|
|
|
|
|
|
IMAB / I-Mab - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
TVTX / Travere Therapeutics, Inc.
|
|
|
|
|
|
|
|
NERV / Minerva Neurosciences, Inc.
|
|
|
|
|
|
|
|
APTO / Aptose Biosciences Inc.
|
|
|
|
|
|
|
|
TCRR / Tcr2 Therapeutics Inc
|
|
|
|
|
|
|
|
BPMC / Blueprint Medicines Corporation
|
|
|
|
|
|
|
|
ZYME / Zymeworks Inc.
|
|
|
|
|
|
|
|
VECT / VectivBio Holding AG
|
|
|
|
|
|
|
|
FMTX / Forma Therapeutics Holdings Inc
|
|
|
|
|
|
|
|
ICVX / Icosavax, Inc.
|
|
|
|
|
|
|
|
ALGS / Aligos Therapeutics, Inc.
|
|
|
|
|
|
|
|
ELDN / Eledon Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
ITOS / iTeos Therapeutics, Inc.
|
|
|
|
|
|
|
|
AKUS / Akouos Inc
|
|
|
|
|
|
|
|
TYRA / Tyra Biosciences, Inc.
|
|
|
|
|
|
|
|
GRPH / Graphite Bio, Inc.
|
|
|
|
|
|
|
|
CCXI / ChemoCentryx Inc
|
|
|
|
|
|
|
|
IMV / IMV Inc
|
|
|
|
|
|
|
|
AVIR / Atea Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
GLTO / Galecto, Inc.
|
|
|
|
|
|
|
|
PLRX / Pliant Therapeutics, Inc.
|
|
|
|
|
|
|
|
RVMD / Revolution Medicines, Inc.
|
|
|
|
|
|
|
|
ATXS / Astria Therapeutics, Inc.
|
|
|
|
|
|
|
|
MORF / Morphic Holding, Inc.
|
|
|
|
|
|
|
|
ERAS / Erasca, Inc.
|
|
|
|
|
|
|
|
MLTX / MoonLake Immunotherapeutics
|
|
|
|
|
|
|
|
RNA / Avidity Biosciences, Inc.
|
|
|
|
|
|
|
|
PHVS / Pharvaris N.V.
|
|
|
|
|
|
|
|
PRAX / Praxis Precision Medicines, Inc.
|
|
|
|
|
|
|
|
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
BMEA / Biomea Fusion, Inc.
|
|
|
|
|
|
|
|
MRTX / Mirati Therapeutics, Inc.
|
|
|
|
|
|
|
|
VRDN / Viridian Therapeutics, Inc.
|
|
|
|
|
|
|
|
ELEV / Elevation Oncology, Inc.
|
|
|
|
|
|
|
|
TALS / Talaris Therapeutics Inc
|
|
|
|
|
|
|
|
MGTX / MeiraGTx Holdings plc
|
|
|
|
|
|
|
|
PYXS / Pyxis Oncology, Inc.
|
|
|
|
|
|
|
|
AVTE / Aerovate Therapeutics, Inc.
|
|
|
|
|
|
|
|
DSGN / Design Therapeutics, Inc.
|
|
|
|
|
|
|
|
HARP / Harpoon Therapeutics, Inc.
|
|
|
|
|
|
|
|
TNGX / Tango Therapeutics, Inc.
|
|
|
|
|
|
|
|
VERV / Verve Therapeutics, Inc.
|
|
|
|
|
|
|
|
AMAM / Ambrx Biopharma Inc.
|
|
|
|
|
|
|
|
TPTX / Turning Point Therapeutics Inc
|
|
|
|
|
|
|
|
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
AXNX / Axonics, Inc.
|
|
|
|
|
|
|
|
IMRX / Immuneering Corporation
|
|
|
|
|
|
|
|
CABA / Cabaletta Bio, Inc.
|
|
|
|
|
|
|
|
TARS / Tarsus Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
YMAB / Y-mAbs Therapeutics, Inc.
|
|
|
|
|
|
|
|
APLS / Apellis Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
LBPH / Longboard Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|